- Report
- November 2025
- 200 Pages
Global
From €7231EUR$7,950USD£6,181GBP
- Report
- November 2025
- 200 Pages
Global
From €7231EUR$7,950USD£6,181GBP
- Report
- November 2025
- 200 Pages
Global
From €7231EUR$7,950USD£6,181GBP
- Report
- November 2025
- 200 Pages
Global
From €7231EUR$7,950USD£6,181GBP
- Report
- November 2025
- 200 Pages
Global
From €7231EUR$7,950USD£6,181GBP
- Report
- November 2025
- 200 Pages
Global
From €7231EUR$7,950USD£6,181GBP
- Report
- May 2026
- 155 Pages
Global
From €3593EUR$3,950USD£3,071GBP
- Report
- November 2025
- 139 Pages
Global
From €4229EUR$4,650USD£3,615GBP
- Report
- July 2026
- 377 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 361 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 390 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 370 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 570 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 294 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 387 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 212 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 383 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 383 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 170 Pages
Global
From €5321EUR$5,850USD£4,548GBP
- Report
- July 2026
- 475 Pages
Global
From €5321EUR$5,850USD£4,548GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more